T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma
- Status
- SUSPENDED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
CD8 Minibody Repeatability Study
- Status
- TERMINATED
- Phase
- PHASE2
Analysis of Circulating Exosomes in Melanoma Patients
- Status
- UNKNOWN
- Phase
- N/A
Pharmacokinetic Profiling of Pembrolizumab and Nivolumab in Patients With Melanoma and/or Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Status
- RECRUITING
- Phase
- PHASE3
KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
- Status
- COMPLETED
- Phase
- N/A
IMM60 and Pembrolizumab in Melanoma and NSCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy
- Status
- COMPLETED
- Phase
- N/A
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
- Status
- COMPLETED
- Phase
- N/A
Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry
- Status
- RECRUITING
- Phase
- N/A
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)
- Status
- TERMINATED
- Phase
- PHASE3